Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings

Expert Review of Molecular Diagnostics

Volumn 16, Issue 4, 2016, Pages 449-459

  Wang, Shuqi ^a,b,c   Lifson, Mark A ^c   Inci, Fatih ^c   Liang, Li Guo ^a,b   Sheng, Ye Feng ^a,b,c   Demirci, Utkan ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c STANFORD UNIVERSITY   (United States)

Author keywords

diagnostics; infectious diseases; pointof care; resourcelimited settings; Technical challenges

Indexed keywords

BIOMEDICAL ENGINEERING; BIOTECHNOLOGICAL PROCEDURES; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; HUMAN; NANOTECHNOLOGY; NONHUMAN; NUCLEIC ACID ANALYSIS; POINT OF CARE TESTING; REVIEW; COMMUNICABLE DISEASES; DEVELOPING COUNTRY; ECONOMICS; MOLECULAR DIAGNOSIS; PROCEDURES; STANDARDS;

COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE TESTING;

EID: 84959050627     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2016.1142877     Document Type: Review

References (79)

1. WHO. Global summary of the HIV/AIDS epidemic; 2014 Dec [cited 2015 Sep 13]. Available from: http://www.who.int/hiv/data/epi- core-july2015.png?ua=1
2. Gandhi NR, Shah NS, Andrews JR, et al. HIV coinfection in multidrugand extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010; 181 (1): 80-86.
3. Williams BG, Dye C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science. 2003; 301 (5639): 1535-1537.
4. WHO. WHO Risk Assessment as of 23 February 2015; 2015 [cited 2015 Sep
5. Available from: http://www.who.int/influenza/human- animal-interface/influenza-h7n9/RiskAssessment-H7N9- 23Feb20115.pdf?ua=1
6. WHO Ebola Response Team. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med. 2014; 371 (16): 1481-1495.
7. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV) maps and epicurves; 2015 [cited 2015 Sep 14]. Available from: http://www.who.int/csr/disease/coronavirus-infections/maps-epi curves-31aug-6sep/en/
8. Wang S, Xu F, Demirci U. Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol Adv. 2010; 28 (6): 770-781.
9. Mani V, Wang S, Inci F, et al. Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care. Adv Drug Deliv Rev. 2014; 78: 105-117.
10. Shafiee H, Wang S, Inci F, et al. Emerging technologies for point-ofcare management of HIV infection. Annu Rev Med. 2015; 66: 387-405.
11. Yildiz UH, Inci F, Wang S, et al. Recent advances in micro/nanotechnologies for global control of hepatitis B infection. Biotechnol Adv. 2015; 33 (1): 178-190.
12. Wang S, Inci F, De Libero G, et al. Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol Adv. 2013; 31 (4): 438-449.
13. Jani IV, Peter TF. How point-of-care testing could drive innovation in global health. N Engl J Med. 2013; 368 (24): 2319-2324.
14. Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu Rev Biomed Eng. 2008; 10: 107-144.
15. Mabey D, Peeling RW, Ustianowski A, et al. Diagnostics for the developing world. Nat Rev Microbiol. 2004; 2 (3): 231-240.
16. Carrilho E, Martinez AW, Whitesides GM. Understanding wax printing: a simple micropatterning process for paper-based microfluidics. Anal Chem. 2009; 81 (16): 7091-7095.
17. Martinez AW, Phillips ST, Whitesides GM. Three-dimensional microfluidic devices fabricated in layered paper and tape. Proc Natl Acad Sci U S A. 2008; 105 (50): 19606-19611.
18. Shafiee H, Asghar W, Inci F, et al. Paper and flexible substrates as materials for biosensing platforms to detect multiple biotargets. Sci Rep. 2015; 5: 8719.
19. Wang S, Zhao X, Khimji I, et al. Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care. Lab Chip. 2011; 11 (20): 3411-3418.
20. Wang S, Esfahani M, Gurkan UA, et al. Efficient on-chip isolation of HIV subtypes. Lab Chip. 2012; 12 (8): 1508-1515.
21. Wang S, Inci F, Chaunzwa TL, et al. Portable microfluidic chip for detection of Escherichia coli in produce and blood. Int J Nanomedicine. 2012; 7: 2591-2600.
22. Wang S, Tasoglu S, Chen PZ, et al. Micro-a-fluidics ELISA for rapid CD4 cell count at the point-of-care. Sci Rep. 2014; 4: 3796.
23. Moon S, Keles HO, Ozcan A, et al. Integrating microfluidics and lensless imaging for point-of-care testing. Biosens Bioelectron. 2009; 24 (11): 3208-3214.
24. Moon S, Gurkan UA, Blander J, et al. Enumeration of CD4+ T-cells using a portable microchip count platform in Tanzanian HIV-infected patients. PLoS One. 2011; 6 (7): e21409.
25. Shafiee H, Jahangir M, Inci F, et al. Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate. Small. 2013; 9 (15): 2553-2563.
26. Shafiee H, Lidstone EA, Jahangir M, et al. Nanostructured optical photonic crystal biosensor for HIV viral load measurement. Sci Rep. 2014; 4: 4116.
27. Tokel, Onur, Fatih Inci, and Utkan Demirci. "Advances in plasmonic technologies for point of care applications." Chemical Reviews. 2014; 114 (11): 5728-5752.
28. Lissandrello C, Inci F, Francom M, et al. Nanomechanical motion of Escherichia coli adhered to a surface. Appl Phys Lett. 2014; 105 (11): 113701.
29. Tokel O, Yildiz UH, Inci F, et al. Portable microfluidic integrated plasmonic platform for pathogen detection. Sci Rep. 2015; 5: 9152.
30. De La Rica R, Stevens MM. Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nat Nanotechnol. 2012; 7 (12): 821-824.
31. Baeumner AJ, Pretz J, Fang S. A universal nucleic acid sequence biosensor with nanomolar detection limits. Anal Chem. 2004; 76 (4): 888-894.
32. Mertens J, Rogero C, Calleja M, et al. Label-free detection of DNA hybridization based on hydration-induced tension in nucleic acid films. Nat Nanotechnol. 2008; 3 (5): 301-307.
33. Posthuma-Trumpie GA, Korf J, van Amerongen A. Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey. Anal Bioanal Chem. 2009; 393 (2): 569-582.
34. Davies PD, Pai M. The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis. 2008; 12 (11): 1226-1234.
35. Tostmann A, Kik SV, Kalisvaart NA, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis. 2008; 47 (9): 1135-1142.
36. Dowdy DW, Steingart KR, Pai M, et al. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a costeffectiveness analysis. PLoS Med. 2011; 8 (8): e1001074.
37. Steingart KR, Flores LL, Dendukuri N, et al. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med. 2011; 8 (8): e1001062.
38. Lawn SD, Kerkhoff AD, Vogt M, et al. Diagnostic accuracy of a lowcost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis. 2012; 12 (3): 201-209.
39. Rosenberg NE, Kamanga G, Phiri S, et al. Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. J Infect Dis. 2012; 205 (4): 528-534.
40. Tasoglu S, Cumhur Tekin H, Inci F, et al. Advances in nanotechnology and microfluidics for human papillomavirus diagnostics. Proc IEEE. 2015; 103 (2): 161-178.
41. Wong AP, Gupta M, Shevkoplyas SS, et al. Egg beater as centrifuge: isolating human blood plasma from whole blood in resource-poor settings. Lab Chip. 2008; 8 (12): 2032-2037.
42. Jiang L, Mancuso M, Lu Z, et al. Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics. Sci Rep. 2014; 4: 4137.
43. Mensing C. Helping patients choose the right blood glucose meter. Nurse Pract. 2004; 29 (5): 43-45.
44. Haemokinesis Ltd. Group Legible Immunohaematology Format; 2015 [cited 2015 Sep 14]. Available from: http://www.haemokinesis.com/products/glif-abd
45. Yeo W-H, Liu S, Chung J-H, et al. Rapid detection of Mycobacterium tuberculosis cells by using microtip-based immunoassay. Anal Bioanal Chem. 2009; 393 (6-7): 1593-1600.
46. Wang Y, Nugen SR. Development of fluorescent nanoparticle-labeled lateral flow assay for the detection of nucleic acids. Biomed Microdevices. 2013; 15 (5): 751-758.
47. Inci F, Filippini C, Baday M, et al. Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics. Proc Natl Acad Sci U S A. 2015; 112 (32): E4354-E4363.
48. Inci F, Tokel O, Wang S, et al. Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood. ACS Nano. 2013; 7 (6): 4733-4745.
49. Gaster RS, Hall DA, Nielsen CH, et al. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat Med. 2009; 15 (11): 1327-1332.
50. Dimov IK, Basabe-Desmonts L, Garcia-Cordero JL, et al. Stand-alone self-powered integrated microfluidic blood analysis system (SIMBAS). Lab Chip. 2011; 11 (5): 845-850.
51. Chin CD, Laksanasopin T, Cheung YK, et al. Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med. 2011; 17 (8): 1015-1019.
52. Martinez AW, Phillips ST, Whitesides GM, et al. Diagnostics for the developing world: microfluidic paper-based analytical devices. Anal Chem. 2010; 82 (1): 3-10.
53. Lisowski P, Zarzycki PK. Microfluidic paper-based analytical devices (muPADs) and micro total analysis systems (muTAS): development, applications and future trends. Chromatographia. 2013; 76: 1201-1214.
54. Pollock NR, Rolland JP, Kumar S, et al. A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing. Sci Transl Med. 2012; 4 (152): 152ra129.
55. Chinnasamy T, Segerink LI, Nystrand M, et al. Point-of-care vertical flow allergen microarray assay: proof of concept. Clin Chem. 2014; 60 (9): 1209-1216.
56. Mudanyali O, Dimitrov S, Sikora U, et al. Integrated rapid-diagnostictest reader platform on a cellphone. Lab Chip. 2012; 12 (15): 2678-2686.
57. Sobieranski, AC, Inci F, Cumhur Tekin H, et al. Portable lensless widefield microscopy imaging platform based on digital inline holography and multi-frame pixel super-resolution. Light Sci Appl. 2015; 4 (10): e346.
58. Al-Soud WA, Radstrom P. Purification and characterization of PCRinhibitory components in blood cells. J Clin Microbiol. 2001; 39 (2): 485-493.
59. Wang S, Sarenac D, Chen MH, et al. Simple filter microchip for rapid separation of plasma and viruses from whole blood. Int J Nanomedicine. 2012; 7: 5019-5028.
60. Tripathi S, Kumar Y, Prabhakar A, et al. Passive blood plasma separation at the microscale: a review of design principles and microdevices. J Micromech Microeng. 2015; 25 (8): 83001.
61. Lukacs Z, Dietrich A, Ganschow R, et al. Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots-a feasibility study using a multi-analyte immunoassay. Clin Chem Lab Med. 2005; 43 (2): 141-145.
62. Boom R, Sol CJA, Salimans MMM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990; 28 (3): 495-503.
63. Govindarajan AV, Ramachandran S, Vigil GD, et al. A low cost pointof- care viscous sample preparation device for molecular diagnosis in the developing world; an example of microfluidic origami. Lab Chip. 2012; 12 (1): 174-181.
64. Rodriguez NM, Linnes JC, Fan A, et al. Paper-based RNA extraction, in situ isothermal amplification, and lateral flow detection for low-cost, rapid diagnosis of influenza A (H1N1) from clinical specimens. Anal Chem. 2015; 87 (15): 7872-7879.
65. Curtis KA, Rudolph DL, Nejad I, et al. Isothermal amplification using a chemical heating device for point-of-care detection of HIV-1. PLoS One. 2012; 7 (2): e31432.
66. LaBarre P, Hawkins KR, Gerlach J, et al. A simple, inexpensive device for nucleic acid amplification without electricity-toward instrumentfree molecular diagnostics in low-resource settings. PLoS One. 2011; 6 (5): e19738.
67. Easley CJ, Karlinsey JM, Bienvenue JM, et al. A fully integrated microfluidic genetic analysis system with sample-in-answer-out capability. Proc Natl Acad Sci U S A. 2006; 103 (51): 19272-19277.
68. Jangam SR, Agarwal AK, Sur K, et al. A point-of-care PCR test for HIV- 1 detection in resource-limited settings. Biosens Bioelectron. 2013; 42: 69-75.
69. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010; 363 (11): 1005-1015.
70. Wade D, Daneau G, Aboud S, et al. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients. J Acquir Immune Defic Syndr. 2014; 66 (5): E98-E107.
71. Pinto IC, Sabido M, Pereira AB, et al. Field evaluation of a point-ofcare CD4 analyzer for monitoring HIV patients in the interior of the Amazon Region, Brazil. PLoS One. 2015; 10 (4): e0121400.
72. Glencross DK, Coetzee LM, Faal M, et al. Performance evaluation of the Pima point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa. J Int AIDS Soc. 2012; 15 (1): 3.
73. Mwau M, Kadima S, Mwende J, et al. Technical performance evaluation of the MyT4 point of care technology for CD4+ T cell enumeration. PLoS One. 2014; 9 (9): e107410.
74. Peng WK, Kong TF, Ng CS, et al. Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis. Nat Med. 2014; 20 (9): 1069-1073.
75. Kong TF, Ye W, Peng WK, et al. Enhancing malaria diagnosis through microfluidic cell enrichment and magnetic resonance relaxometry detection. Sci Rep. 2015; 5: 11425.
76. Kumar AA, Patton MR, Hennek JW, et al. Density-based separation in multiphase systems provides a simple method to identify sickle cell disease. Proc Natl Acad Sci U S A. 2014; 111 (41): 14864-14869.
77. Durmus NG, Tekin C, Guven S, et al. Magnetic levitation of single cells. Proc Natl Acad Sci U S A. 2015; 112 (28): E3661-E3668.
78. Tasoglu S, Khoory JA, Tekin HC, et al. Levitational image cytometry with temporal resolution. Adv Mater. 2015; 27 (26): 3901-3908.
79. Derda R, Gitaka J, Klapperich CM, et al. Enabling the development and deployment of next generation point-of-care diagnostics. PLoS Negl Trop Dis. 2015; 9 (5): e0003676.